Moderna Inc annual shares outstanding for fiscal TTM was 395 million shares, an increase of 1.5% from 389 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Shares Outstanding (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 395M | 389M | 384M | 382M | 416M | 431M | 381M | 331M | 81M | 376M | 376M | 61M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Shares Outstanding (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 395M | 392M | 390M | 388M | 386M | 385M | 399M | 384M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRNA metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow
All MRNA financial statements → Interactive MRNA charts →
About TickerBase · Data methodology & sources